FIRST-LINE TREATMENT: SLT OR MEDICATION? Medication has historically been the gold standard, but recent success with SLT is giving surgeons more options.

The article focuses on comparing selective laser trabeculoplasty (SLT) with medication as first-line treatments for glaucoma. It discusses the advantages and disadvantages of each approach, including patient compliance, safety, efficacy, and long-term outcomes, drawing on recent clinical trials and expert opinions. It also mentions the considerations for choosing between SLT and medication based on factors such as disease severity, patient preferences, and cost-effectiveness.